Nektar Therapeutics (NKTR) stock
NKTRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$35.91−0.53 (-1.45%)
Close on Nov 17, 2026Market cap $1.23BP/E –Yield –
Nektar Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Nektar Therapeutics's enterprise value was $99.02M on Nov 11, 2026, against $1.01B a year earlier. Over the last 5 years it ranged from -$372.98M to $1.57B, with a median of -$20.14M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $99.02M | -82.3% |
| 2025 | Dec 31, 2025 | $560.70M | – |
| 2024 | Dec 31, 2024 | -$72.96M | – |
| 2023 | Dec 29, 2023 | -$265.83M | – |
| 2022 | Dec 30, 2022 | -$121.63M | -107.7% |
| 2021 | Dec 31, 2021 | $1.57B | -24.9% |
| 2020 | Dec 31, 2020 | $2.09B | -8.9% |
| 2019 | Dec 31, 2019 | $2.30B | -46.1% |
| 2018 | Dec 31, 2018 | $4.27B | -54.3% |
| 2017 | Dec 29, 2017 | $9.33B | +473.6% |
| 2016 | Dec 30, 2016 | $1.63B | -26.9% |
| 2015 | Dec 31, 2015 | $2.23B | +13.8% |
| 2014 | Dec 31, 2014 | $1.96B | +56.3% |
| 2013 | Dec 31, 2013 | $1.25B | +48.5% |
| 2012 | Dec 31, 2012 | $842.35M | +360.8% |
| 2011 | Dec 30, 2011 | $182.79M | – |
See a number that looks wrong?